• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Podcast: This Week in Managed Care—Patient-Reported Outcomes With CAR T and Other Health News

Podcast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included a panel mostly endorsed the use of patient-reported outcomes for coverage of chimeric antigen receptor T-cell therapy; the US Preventive Services Task Force released new recommendations for cervical cancer screening; research found accountable care organization penetration may be changing how physicians work.

To listen, login to the website.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

Many Questions to Ask in Setting National Coverage for CAR T Therapies

MEDCAC Panel Mostly Endorses PROs for CAR T Therapies

USPSTF Updates Cervical Cancer Screening Recommendations

ACO Penetration Linked to Decreased Work Hours, Less Self-Employment

Substituting Brand-Name Combinations for Generics Could Have Saved Medicare $925 Million in 2016

Payment Reform Reveals Value of Diabetes Educators in Driving Down Healthcare Costs, Joslin's Gabbay Says

American Association of Diabetes Educators 2018

Evidence-Based Oncology—August 2018

Read more about the stories in this podcast:

Related Videos
Dr Sundar Jagannath
Ayodeji Adegunsoye, MD, PhD, MSc
Dr Caroline Vovan
Dr Caroline Vovan
Dr Caroline Vovan
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Related Content
Dordaviprone is indicated for recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affecting children. | Image credit: wladimir1804 - stock.adobe.com

FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma

August 6th 2025
Article

Dordaviprone (Modeyso) is now approved to treat recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affecting children.

Read More

managed care cast logo

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

July 24th 2025
Podcast

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

Gen Li, PhD, MBA, president and founder of Phesi

Real-World Data, Digital Patient Profiles Are Revolutionizing Trial Design, Patient Recruitment: Gen Li, PhD, MBA

August 4th 2025
Article

Digital patient profiles and expansive real-world data are reshaping oncology clinical trials, explained Gen Li, PhD, MBA, president and founder of Phesi.

Read More

Managed Care Cast

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

July 15th 2025
Podcast

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

Listen

Value-based care. | Image Credit: irissca - stock.adobe.com

Legal Navigation Services Key to Addressing Disparities in Cancer Care

July 31st 2025
Article

A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.

Read More

AJMC

Price Transparency and Patient Engagement: Social Messaging Matters

July 31st 2025
Article

This study examined the impact of price transparency and prosocial messaging on patient engagement of price-protected consumers in seeking value-based care.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.